Effects of simulated bleeding in an in vitro nasal fibroblast wound healing model

American Journal of Rhinology and Allergy

Volumn 24, Issue 3, 2010, Pages 186-191

  Beule, Achim Georg ^a,b   Athanasiadis, Theodore ^b   Field, John ^b   Hosemann, Werner ^a   Wormald, Peter John ^b   Tan, Lor Wai ^b  

^a UNIVERSITY OF GREIFSWALD   (Germany)

^b UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

Bleeding; Chronic rhinosinusitis; Endoscopic sinus surgery; Fibroblasts; Matrix metalloproteinases; Plasminogen; Tranexamic acid; Wound healing model

Indexed keywords

GELATINASE A; GELATINASE B; MATRIX METALLOPROTEINASE; PLASMINOGEN; TISSUE PLASMINOGEN ACTIVATOR; TRANEXAMIC ACID; UROKINASE;

ADOLESCENT; ADULT; AGED; ARTICLE; CELL CULTURE; CELL MIGRATION; CELL PROLIFERATION; CHEMOTAXIS; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOSCOPIC SINUS SURGERY; ENZYME ACTIVITY; EPISTAXIS; FEMALE; FIBROBLAST; HUMAN; HUMAN CELL; IN VITRO STUDY; INFORMED CONSENT; MALE; NOSE FIBROBLAST; NOSE POLYP; PLASMINOGEN ACTIVATION; PROTEIN EXPRESSION; RHINOSINUSITIS; SIMULATION; WOUND HEALING;

BIOLOGICAL MARKERS; CELL PROLIFERATION; CELLS, CULTURED; CHRONIC DISEASE; FIBROBLASTS; HEMORRHAGE; HUMANS; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; NOSE; PLASMINOGEN; RHINITIS; SINUSITIS; TISSUE PLASMINOGEN ACTIVATOR; TRANEXAMIC ACID; UROKINASE-TYPE PLASMINOGEN ACTIVATOR; WOUND HEALING;

EID: 77953640957     PISSN: 19458924     EISSN: 19458932     Source Type: Journal    
DOI: 10.2500/ajra.2010.24.3452     Document Type: Article

References (26)

1. Watelet JB, Demetter P, Claeys C, et al. Neutrophil-derived metalloproteinase-9 predicts healing quality after sinus surgery. Laryngoscope 115:56-61, 2005.
2. Watelet JB, Claeys C, van Cauwenberge P, and Bachert C. Matrix metalloproteinases in chronic sinus diseases. Int Congr Ser 1240:483-485, 2003.
3. Edwards DR, Murphy G, Reynolds JJ, et al. Transforming growth factor beta modulates the expression of collagenase and metalloproteinase inhibitor. EMBO J 6:1899-1904, 1987.
4. Lechapt-Zalcman E, Coste A, d'Ortho MP, et al. Increased expression of matrix metalloproteinase-9 in nasal polyps. J Pathol 193:233-241, 2001.
5. Shaida A, Kenyon G, Devalia J, et al. Matrix metalloproteinases and their inhibitors in the nasal mucosa of patients with perennial allergic rhinitis. J Allergy Clin Immunol 108:791-796, 2001.
6. Asano K, Kanai KI, and Suzaki H. Suppressive activity of fexofenadine hydrochloride on metalloproteinase production from nasal fibroblasts in vitro. Clin Exp Allergy 34:1890-1898, 2004.
7. Kanai S, Asano K, and Hisamitsu T. Suppression of matrix metalloproteinase production from nasal fibroblasts by macrolide antibiotics in vitro. Eur Resp J 23:671-678, 2004. (Pubitemid 38618134)
8. Namba M, Asano K, and Kanai S. Suppression of matrix metalloproteinase production from nasal fibroblasts by fluticasone propionate in vitro. Acta Otolaryngol 124:964-969, 2004. (Pubitemid 39371578)
9. Platt MP, Cunnane ME, Curtin HD, and Metson R. Anatomical changes of the ethmoid cavity after endoscopic sinus surgery. Laryngoscope 118:2240-2244, 2008.
10. Watelet JB, Claeys C, Van Cauwenberge P, and Bachert C. Predictive and monitoring value of matrix metalloproteinase-9 for healing quality after sinus surgery. Wound Repair Regen 12:412-418, 2004.
11. Lijnen HR, Silence J, Lemmens G, et al. Regulation of gelatinase activity in mice with targeted inactivation of components of the plasminogen/plasmin system. Thromb Haemost 79:1171-1176, 1998.
12. Li WY, Chong SS, Huang EY, and Tuan TL. Plasminogen activator/ plasmin system: A major player in wound healing? Wound Repair Regen 11:239-247, 2003.
13. Beule AG, Wilhelmi F, Kuhnel TS, et al. Propofol versus sevoflurane: Bleeding in endoscopic sinus surgery. Otolaryngol Head Neck Surg 136:45-50, 2007.
14. Kupferberg SB, Bent JP III, and Kuhn FA. Prognosis for allergic fungal sinusitis. Otolaryngol Head Neck Surg 117:35-41, 1997.
15. Athanasiadis T, Beule AG, and Wormald PJ. Effects of topical antifibrinolytics in endoscopic sinus surgery: A pilot randomized controlled trial. Am J Rhinol 21:737-742, 2007.
16. Sabba C, Gallitelli M, and Palasciano G. Efficacy of unusually high doses of tranexamic acid for the treatment of epistaxis in hereditary hemorrhagic telangiectasia. N Engl J Med 345:926, 2001.
17. Coker N, and Higgins DJ. Tranexamic acid applied topically to achieve haemostasis. Anaesthesia 55:600-601, 2000. (Pubitemid 30345044)
18. Tan L, Hatzirodos N, and Wormald PJ. Effect of nerve growth factor and keratinocyte growth factor on wound healing of the sinus mucosa. Wound Repair Regen 16:108-116, 2008.
19. Wang W, Chen HJ, Giedd KN, et al. T-cell lymphokines, interleukin-4 and gamma interferon, modulate the induction of vascular smooth muscle cell tissue plasminogen activator and migration by serum and platelet-derived growth factor. Circ Res 77:1095-1106, 1995.
20. R Development Core Team. R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. ISBN 3-900051-07-0, 2009. Available online at www. R-project.org; last accessed March 2010.
21. Duerr S, Wendler O, Aigner T, et al. Metalloproteinases in juvenile angiofibromas-A collagen rich tumor. Hum Pathol 39:259-268, 2008.
22. Iwamoto J, Takahashi K, Mizokami Y, et al. Expression of urokinasetype plasminogen activator and its receptor in gastric fibroblasts and effects of nonsteroidal antiinflammatory drugs and prostaglandin. Dig Dis Sci 48:2247-2256, 2003.
23. Takahashi K, Uwabe Y, Sawasaki Y, et al. Increased secretion of urokinase-type plasminogen activator by human lung microvascular endothelial cells. Am J Physiol 275:L47-L54, 1998.
24. Ugwu F, Lemmens G, Collen D, and Lijnen HR. Matrix metalloproteinase deficiencies do not impair cell-associated fibrinolytic activity. Thromb Res 102:61-69, 2001.
25. Hajjar K. The molecular basis of fibrinolysis. In Hematology of Infancy and Childhood. Nathan DOS, and Ginsburg D (Eds). Philadelphia, PA: WB Saunders Co., 1497-1514, 2003.
26. Watelet JB, Bachert C, Claeys C, and Van Cauwenberge P. Matrix metalloproteinases MMP-7, MMP-9 and their tissue inhibitor TIMP-1: Expression in chronic sinusitis vs nasal polyposis. Allergy 59:54-60, 2004.